Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2869662/0/en/NurExone-Biologic-Inc-Announces-Strategic-Expansion-to-US-Financial-Markets-with-Approval-of-OTCQB-Listing-Application-and-DTC-Eligibility.html
https://www.globenewswire.com/news-release/2024/04/19/2866360/0/en/NurExone-Presenting-on-Revolutionary-Spinal-Cord-Injury-Therapy-at-European-Conference-on-Exosomes-and-Regenerative-Medicine.html
https://www.globenewswire.com/news-release/2024/04/02/2855975/0/en/NurExone-Reports-Fourth-Quarter-and-Year-Ended-December-31-2023-Financial-Results-and-Provides-Company-Update.html
https://www.globenewswire.com/news-release/2024/03/27/2853650/0/en/Gross-Proceeds-Close-of-4M-CAD-Generated-for-NurExone-From-Warrants-Exercise.html
https://www.globenewswire.com/news-release/2024/03/22/2851157/0/en/In-Preparation-for-Expected-Human-Clinical-Trials-NurExone-Signs-Agreement-for-Large-Scale-Preclinical-Testing-for-Its-Spinal-Cord-Injury-Therapy-ExoPTEN.html
https://www.globenewswire.com//news-release/2024/03/15/2847297/0/en/NurExone-s-Strategic-Update-Submission-of-OTCQB-Listing-Application-to-Initiate-US-financial-presence.html
https://www.globenewswire.com/news-release/2024/03/08/2843320/0/en/NurExone-establishing-State-of-the-Art-Research-and-Development-Facility-in-Haifa-Israel.html
https://www.globenewswire.com//news-release/2024/03/01/2839059/0/en/NurExone-Presenting-Novel-Regulatory-Pathways-for-Exosomes-Therapies-at-Global-Summit.html
https://www.globenewswire.com//news-release/2024/02/20/2832280/0/en/NurExone-s-Intellectual-Property-Portfolio-Expands.html
https://www.globenewswire.com//news-release/2024/02/14/2829477/0/en/NurExone-Launches-Licensing-Efforts-for-ExoTherapy-Platform.html